JPMorgan Chase & Co. Reaffirms "Overweight" Rating for Shire PLC


Other equities research analysts have also recently issued reports about the company. Jefferies Group boosted their price objective on Shire PLC from GBX 6,050 to GBX 6,600 and gave the company a "buy" rating in a research note on Wednesday, August 3rd.



from Biotech News